[ad_1] SHANGHAI, Nov. 4, 2024 /PRNewswire/ — BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062, a selective endothelin receptor type A (ETA) antagonist, for the treatment of IgA Nephropathy (IgAN). […]
Trending Stories
MAPS Investors Have Opportunity to Lead WM Technology, Inc. Securities Class Action First Filed by the Firm
[ad_1] NEW YORK, Nov. 4, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of WM Technology, Inc. (NASDAQ: MAPS) between May 25, 2021, and September 24, 2024, […]
DeepRoute.ai Announces Major Series C1 Funding; Strategic Investment from Prestigious Chinese Automotive OEM
[ad_1] SHENZHEN, China, Nov. 4, 2024 /PRNewswire/ — DeepRoute.ai, the leading artificial intelligence company specializing in developing smart driving solutions, announced a strategic Series C1 funding round, raising US$100 million from prestigious Chinese automotive OEM. The […]
Rowley Law PLLC is Investigating Proposed Acquisition of Air Transport Services Group, Inc.
[ad_1] NEW YORK, Nov. 4, 2024 /PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Air Transport Services Group, Inc. (NASDAQ: ATSG) and its board of directors concerning the proposed acquisition of […]
GOLD ROYALTY REPORTS THIRD QUARTER 2024 RESULTS; RECORD REVENUE FOR THE FIRST NINE MONTHS OF 2024
[ad_1] VANCOUVER, BC, Nov. 4, 2024 /PRNewswire/ – Gold Royalty Corp. (“Gold Royalty” or the “Company“) (NYSE American: GROY) is pleased to announce the filing of its operating and financial results for the three and […]
